Passengers flying in airplanes with recirculated air report no more colds than do people traveling in planes using 100 percent fresh air for ventilation, according to a “natural experiment” conducted by scientists at the University of California, San Francisco and their colleagues. The study involved more than 1,000 passengers flying between the San Francisco Bay area and Denver during the winter and early spring of 1999. About 19 percent of passengers on planes with recirculated cabin air reported colds one week after the flight.
July 22, 2002
This month sixteen graduates of international dental schools will complete the first year in the UCSF School of Dentistry’s first International Dental Program (IDP). “UCSF was asked in 1997 by the California state legislature to consider providing this program for international dentists,” explained William Bird, DDS, DPh, UCSF clinical professor of prevention and restorative dental science and director of the IDP.
July 19, 2002
Twenty Bay Area high school students are participating in a six-week residential program designed to improve their knowledge in math and chemistry while exposing them to health profession careers at the University of California, San Francisco. The UCSF Health Sciences Enrichment Program (HSEP) began classes on June 17 with 16 students from UCSF’s partnership with San Francisco high schools (Thurgood Marshall, Phillip and Sala Burton and Mission) and four from Bay Area high schools.
July 16, 2002
WHAT: UCSF’s recently completed Islet and Cellular Transplantation Facility, where insulin-secreting islet cells can be retrieved from a donated pancreas, will allow UCSF surgeons this fall to perform Northern California’s first islet transplantation - an experimental treatment that restores the ability of Type 1 diabetics to produce their own insulin.
July 11, 2002
In Zimbabwe, rape is all too common and negotiating safe sex to prevent infection with HIV is almost impossible for many adolescent girls because involvement with older men in return for material benefits is widespread, according to researchers from UCSF.
July 11, 2002
BARCELONA - Growth hormone may stimulate the production of T cells in HIV-infected patients, research at the Gladstone Institute of Virology and Immunology shows. T cells are the immune system cells that HIV attacks and destroys, leaving patients without defenses against the opportunistic infections of AIDS. Laura Napolitano, MD, lead investigator of the study, presented the research on July 11 at the 14th International AIDS Conference here in Barcelona. Napolitano is a staff research investigator at Gladstone and UCSF assistant professor of medicine.
July 11, 2002
Three percent of HIV-infected gay men in New York and San Francisco had a current syphilis infection, half of one percent had a current case of chlamydia or gonorrhea when tested between 2000-2001, according to UCSF researchers.
July 09, 2002
Almost all (98 percent) Zimbabwean women who were unable to persuade their male partners to use condoms consistently, used the diaphragm as an alternative method of contraception and disease prevention, though its effectiveness against HIV remains unknown, UCSF researchers have found.
July 08, 2002
WHAT A celebration of the Avon Foundation’s gifts of $12.2 million (to-date) to the partnership between San Francisco General Hospital Medical Center (SFGHMC) and University of California, San Francisco (UCSF) The UCSF digital Mammovan, supported in part by Avon funds, will be available for tours at approximately 11:30 on the street at 401 Van Ness WHERE Veteran’s Building at 401 Van Ness Ave, San Francisco Green Room, second floor WHEN 10:30 am - noon Wednesday (July 10) Program begins at 11 am (See detailed schedule, below)
July 08, 2002
Young gay men-ages 18 to 28-in Albuquerque reported a 12% decrease in risky sexual behavior as a result of a community building HIV prevention intervention. Similar cohorts in Austin and Phoenix who did not receive the intervention reported increases of 42% and 26% respectively, when compared to risky behavior rates prior to the introduction of HAART (Highly Active Anti-Retroviral Therapy) in 1996, say researchers at UCSF’s Center for AIDS Prevention Studies (CAPS).